Thrivent Financial for Lutherans Cuts Holdings in Mettler-Toledo International, Inc. $MTD

Thrivent Financial for Lutherans lowered its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 53.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,635 shares of the medical instruments supplier’s stock after selling 9,989 shares during the period. Thrivent Financial for Lutherans’ holdings in Mettler-Toledo International were worth $10,144,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. WPG Advisers LLC purchased a new position in shares of Mettler-Toledo International in the 1st quarter valued at about $41,000. NewSquare Capital LLC grew its holdings in Mettler-Toledo International by 94.4% in the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 17 shares during the period. MV Capital Management Inc. increased its position in shares of Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares in the last quarter. State of Wyoming purchased a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $58,000. Finally, Sound Income Strategies LLC raised its stake in shares of Mettler-Toledo International by 477.8% during the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Trading Down 0.1%

NYSE:MTD opened at $1,384.84 on Thursday. The company has a market cap of $28.29 billion, a P/E ratio of 34.53, a P/E/G ratio of 4.48 and a beta of 1.40. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,525.17. The company’s 50-day moving average price is $1,406.27 and its 200-day moving average price is $1,297.87.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the prior year, the firm earned $10.21 EPS. Mettler-Toledo International’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,880 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total transaction of $9,976,000.00. Following the transaction, the insider owned 187 shares of the company’s stock, valued at approximately $271,150. The trade was a 97.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gerry Keller sold 236 shares of the company’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the sale, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. The trade was a 59.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 19,565 shares of company stock valued at $28,683,737 in the last 90 days. 1.94% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on MTD shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday. Morgan Stanley started coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 target price on the stock. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday. The Goldman Sachs Group initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target on the stock. Finally, Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research note on Monday. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,441.67.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.